The establishment of Hua Medicine’s pharmaceutical sales and marketing team resulted in significant sales growth in the first two months of 2025, opening a new model of innovative drug ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

RARE opened at $37.82 on Tuesday. Ultragenyx Pharmaceutical has a fifty-two week low of $36.71 and a fifty-two week high of $60.37. The stock has a fifty day moving average of $41.64 and a 200-day ...

Much has been written about the demise of the traditional pharmaceutical sales model and the “Complex Buying Environment” that now pervades within our industry. The reasons have been well docu ...

More than 6000 rare diseases—those which affect fewer than one in 2000 people each—are acknowledged in the medical community, with 72% of them being genetic.

Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

But they will pay more if property taxes are replaced by higher sales taxes. Homeowners earning $100,000 a year spend all their wages on their mortgage, food, insurance, car, clothes, medicine and ...

The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. But in the wake of the COVID-19 pandemic, there is an even greater need to re-examine the rep's role.

Part 1. Deportations In The First Red Scare Guest: Chris Finan is an author and historian. He worked as a free speech activist for over 40 years and led several groups, including the National ...

The Post welcomes letters up to 250 words on topics of general interest. Letters must include full name, home address, day and evening phone numbers, and may be edited for length, grammar and ...

Trump has repeatedly called April 2 "Liberation Day," with promises to roll out a set of tariffs, or taxes on imports from ...